Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Pruritus | 25% | x | x | |
Hypotension | 2% - 7% | x | x | |
Hypertension | 3% | x | x | |
Muscle rigidity | 3% | x | x | |
Bradycardia | 3% | x | x | |
Dizziness | 2% | x | ||
Shivering | 2% | x | ||
Euphoric mood | 2% | x | ||
Body temperature increased | 1% | x | ||
Miosis | 1% | x | ||
Urinary incontinence | 1% | x | ||
Injection site pain | 1% | x | ||
Anaphylactic shock | x | |||
Apnoea | x | x | ||
Arrhythmia | x | x | ||
Bronchospasm | x | x | ||
Confusional state | x | |||
Rash | x | |||
Headache | x | |||
Cardiac arrest | x | x | ||
Hypersensitivity | x | |||
Laryngospasm | x | |||
Nausea | x | x | ||
Tachycardia | x | x | ||
Erythema | x | |||
Urinary tract disorder | x | |||
Vomiting | x | x | ||
Urinary retention | x | x | ||
Chills | x | x | ||
Respiratory depression | x | x | ||
Hypopnoea | x | |||
Somnolence | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Pain | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |